Dan Liu | Medicine and Dentistry | Best Researcher Award

Posted on 20/11/202420/11/2024 by Book of Award

Dr. Dan Liu | Medicine and Dentistry | Best Researcher Award

General Hospital of Ningxia Medical University | China

Author Profile

🌱 Early Academic Pursuits

Dr. Dan Liu began her distinguished journey with a strong foundation in medicine and research. Her academic rigor led her to advanced positions, including her role as a doctoral supervisor and principal investigator. She gained international exposure as a visiting scholar at the University of Iowa and Texas Medical Center, further enhancing her global perspective and expertise in medical sciences.

💼 Professional Endeavors

Currently, Dr. Liu serves as the director of the Ningxia Hysteroscopy Diagnosis and Treatment Center and plays a pivotal role at the General Hospital of Ningxia Medical University. Her leadership in hysteroscopy diagnostics has transformed the medical landscape in Ningxia. Beyond clinical duties, she actively drives innovation and research, influencing medical sciences both regionally and nationally.

🔬 Contributions and Research Focus

Dr. Liu's research portfolio is impressive, including two projects funded by the National Natural Science Foundation of China and one significant national-grade project. She has successfully integrated technological advancements into her field, holding one utility model patent and one invention patent. Her pioneering contributions address critical challenges in women’s health, making significant strides in hysteroscopy techniques and diagnostics.

🏆 Accolades and Recognition

Dr. Liu’s accomplishments have garnered numerous awards, such as the prestigious second prize of the Science and Technology Progress Award of Ningxia Autonomous Region. In 2023, her dedication and exceptional service earned her the "Special Contribution" Award from People’s Daily Online, recognizing her as an excellent doctor. These accolades underscore her impact on medical innovation and patient care.

🌟 Impact and Influence

Through her dual roles in clinical practice and academia, Dr. Liu has shaped the next generation of medical professionals while advancing the field of hysteroscopy. Her leadership in research and treatment has set new benchmarks, directly benefiting patients and fostering a culture of innovation in the medical community.

🔮 Legacy and Future Contributions

As a trailblazer in her field, Dr. Liu’s legacy is one of excellence and commitment to advancing healthcare. Her ongoing projects and visionary leadership promise continued contributions to medical science, inspiring future researchers and clinicians to follow her path of innovation and service.

Publications

📝 Meta-analysis of FOXP3 polymorphisms and recurrent spontaneous abortion susceptibility
Authors: Shuai, R., Li, D., Xu, X., Yang, X., Liu, D.
Journal: American Journal of Reproductive Immunology
Year: 2024

📝 The osteogenesis and the biologic mechanism of thermo-responsive injectable hydrogel containing carboxymethyl chitosan/sodium alginate nanoparticles towards promoting osteal wound healing
Authors: Shi, Z., Yang, F., Pang, Q., Zhu, Y.
Journal: International Journal of Biological Macromolecules
Year: 2023

📝 Bone marrow mesenchymal stem cells combined with estrogen synergistically promote endometrial regeneration and reverse EMT via Wnt/β-catenin signaling pathway
Authors: Yuan, L., Cao, J., Hu, M., Chen, M., Liu, D.
Journal: Reproductive Biology and Endocrinology
Year: 2022

📝 A novel intrauterine barrier for preventing the recurrence of IUA after TCRA procedure
Authors: Chen, M., Yuan, L., Jin, H., Zhang, X., Liu, D.
Journal: Medical Hypotheses
Year: 2022

📝 Organoid Transplantation Can Improve Reproductive Prognosis by Promoting Endometrial Repair in Mice
Authors: Zhang, H., Xu, D., Li, Y., Li, G., Liu, D.
Journal: International Journal of Biological Sciences
Year: 2022

Yanhua Wang | Medicine and Dentistry | Best Researcher Award

Posted on 18/11/202418/11/2024 by Book of Award

Dr. Yanhua Wang | Medicine and Dentistry | Best Researcher Award

Shanxi Aier Eye Hospital | China

Author Profile

Scopus

Orcid

Early Academic Pursuits 📚

Dr. Yanhua Wang's journey in ophthalmology began with her Bachelor's degree in Clinical Medicine from Shanxi Changzhi Medical University in 1998. She pursued advanced studies, earning an MD in Ophthalmology and a PhD from Southwest Eye Hospital, General Medical University in Chongqing, China. Her academic trajectory was further enriched with a postdoctoral fellowship at the Department of Ophthalmology, General Hospital of PLA, Beijing, in 2013. This solid foundation equipped her with expertise in cutting-edge ophthalmic research and clinical care.

Professional Endeavors 💼

Dr. Wang's career spans over two decades, marked by her tenure as Deputy Chief Physician at Jinhzhong Hospital, Shanxi Province, where she served until 2016. Currently, she is the Chief Physician at the Department of Pediatric Ophthalmology & Optometry, Shanxi Aier Eye Hospital, part of the Aier Eye Hospital Group. Her role emphasizes innovative treatments and advanced care for pediatric ocular conditions, solidifying her as a leader in her field.

Contributions and Research Focus 🧠🔬

Dr. Wang’s research delves into the mechanisms underlying retinal neuron survival, optic nerve regeneration, and pediatric strabismus. Her studies on alpha-crystallin’s neuroprotective effects and its role in axonal regeneration have pioneered new therapeutic pathways. Through publications in journals such as Journal of Ophthalmology and Neuroscience Letters, she has significantly advanced understanding in these domains. She has also innovated patented technologies, including intelligent examination devices and surgical support structures, showcasing her dedication to translational research.

Accolades and Recognition 🏆

Dr. Wang has received numerous accolades, including the Chongqing Second Prize for Scientific and Technological Progress in 2013. She has secured major grants from prestigious institutions, such as the National Natural Science Foundation of China, the China Postdoctoral Science Foundation, and the Aier Eye Hospital Group Foundation. These honors reflect her impactful contributions to ophthalmology and translational medicine.

Impact and Influence 🌍

Dr. Wang’s work has had a profound influence on pediatric ophthalmology, offering novel diagnostic and therapeutic solutions for conditions like strabismus. Her patented inventions have enhanced clinical precision and patient outcomes, and her research has provided valuable insights into neuroprotection and nerve regeneration. Her leadership in clinical care and her scientific achievements continue to inspire and guide the next generation of ophthalmologists.

Legacy and Future Contributions 🌟

With her unwavering commitment to pediatric ophthalmology and groundbreaking research, Dr. Yanhua Wang's legacy is one of innovation and compassion. Her future contributions promise to bridge clinical advancements with cutting-edge research, ensuring better ocular health outcomes for children worldwide. Through her continued efforts, Dr. Wang is poised to leave an indelible mark on ophthalmology and medical science.

Publications

📝 Characteristics of Peripheral Retinal Refraction and Its Role in Children with Different Refractive States
Authors: Qi Zhao, Yanhua Wang*, Tiangang Liang, Weixiang Nie, Pei Xue, Jie Cheng
Journal: Journal of Ophthalmology
Year: 2024

📝 Synergistic Effect of Olfactory Ensheathing Cells and Alpha-Crystallin on Restoration of Adult Rat Optic Nerve Injury
Authors: Wang, Y.H., Yin, Z.Q., Wang, Y.
Journal: Neuroscience Letters
Year: 2017

📝 Leber's Hereditary Optic Neuropathy is Associated with Compound Primary Mutations of Mitochondrial ND1 m.3635G > A and ND6 m.14502 T > C
Authors: Jin, X., Wang, L., Gong, Y., Chen, T., Wei, S.
Journal: Ophthalmic Genetics
Year: 2015

📝 Alpha-Crystallin Promotes Rat Olfactory Ensheathing Cells Survival and Proliferation through Regulation of PI3K/Akt/mTOR Signaling Pathways
Authors: Wang, Y.H., Li, Y.C., Huo, S.J., Yin, Z.Q.
Journal: Neuroscience Letters
Year: 2012

📝 Alpha-Crystallin Promotes Rat Axonal Regeneration through Regulation of RhoA/Rock/Cofilin/MLC Signaling Pathways
Authors: Wang, Y.H., Wang, D.W., Wu, N., Wang, Y., Yin, Z.Q.
Journal: Journal of Molecular Neuroscience
Year: 2012

Inmaculada Gilaberte | Medicine and Dentistry | Best Researcher Award

Posted on 13/11/202413/11/2024 by Book of Award

Dr. Inmaculada Gilaberte | Medicine and Dentistry | Best Researcher Award

FAES Farma | Spain

Author Profile

Scopus

🌱 Early Academic Pursuits

Dr. Inmaculada Gilaberte’s academic journey is rooted in a commitment to excellence and medical advancement. She initially pursued education in clinical research, equipping herself with in-depth knowledge and skills in therapeutic areas such as neuroscience and immunology. Her academic foundation was further strengthened by certifications, including a lecturer certification from the Spanish Quality Register Agency (ANECA), and advanced leadership programs from institutions like Stanford and MIT. These formative experiences shaped her growth mindset, laying the groundwork for a career dedicated to precision, patient-centered care, and effective team collaboration.

💼 Professional Endeavors

Throughout her career, Dr. Gilaberte has held prominent roles in major pharmaceutical companies such as FAES FARMA, Takeda, TiGenix, Roche, and Lilly, with positions spanning from Clinical Research Physician to Director of Clinical Research. She has led various departments, managed global teams, and directed clinical trials across multiple therapeutic areas, including gastroenterology, immunology, cardiology, and pain management. Her strategic guidance has driven several landmark projects forward, including the advancement of microbiome and cell therapies from preclinical to first-in-human trials, demonstrating her expertise in transforming innovative therapies into viable treatment options.

🧬 Contributions and Research Focus

Dr. Gilaberte has made notable contributions to clinical research, particularly in stem cell therapy, immunology, and neuroscience. Her pioneering work on Darvadstrocel, an allogeneic adipose-derived mesenchymal stem cell therapy, led to significant strides in treating perianal fistulas and positioned her as a leader in regenerative medicine. She has been instrumental in launching global clinical trials, developing target product profiles (TPP), and submitting regulatory applications for FDA and EMA approvals. With a robust publication record, including 66 papers indexed in PubMed, she continues to contribute to scientific literature, sharing her findings and advancing the field of biomedicine.

🏆 Accolades and Recognition

Dr. Gilaberte’s excellence has been recognized through numerous awards across her roles in clinical development and leadership. Her achievements include multiple awards for her work in the clinical progression of innovative therapies and successful drug submissions to global regulatory bodies. She has received recognition for her strategic contributions to the Darvadstrocel trials and for advancing neuroscience programs in Alzheimer’s disease. Her leadership has earned her high regard in the industry, with acknowledgments from institutions and colleagues alike.

🌍 Impact and Influence

Dr. Gilaberte’s impact extends beyond her immediate professional roles. Her contributions to clinical science have enhanced treatment options for patients with complex diseases, and her leadership has shaped clinical strategies in multinational pharmaceutical companies. She has also promoted effective collaboration across global, cross-functional teams, fostering a diverse and inclusive work environment that prioritizes patient needs. Her initiatives in regulatory compliance, risk management, and data integration have set new standards for clinical operations, solidifying her influence as a thought leader in her field.

📜 Legacy and Future Contributions

Looking ahead, Dr. Gilaberte’s legacy is one of commitment to advancing patient care through innovation, collaboration, and strategic foresight. Her future endeavors are poised to make an enduring impact, with ongoing research and leadership contributions that will shape the future of clinical development. Her philanthropic work, such as building a nursery in Uganda, highlights her dedication to global well-being beyond her professional achievements. Dr. Gilaberte continues to inspire the next generation of clinical researchers, ensuring that her legacy of precision, empathy, and patient-first innovation will endure.

Publications

📄 Efficacy and Safety of Weekly Calcifediol Formulations (75 and 100 µg) in Subjects with Vitamin D Deficiency: A Phase II/III Randomised Trial

Authors: Esteban Jódar-Gimeno, Jose Luis Pérez-Castrillón, Ján Nociar, Michal Lojka, Dimitar Nikolov, Fernando Cereto-Castro, Snežana Novković, Umberto Tarantino, Nadia Mehsen-Cetre, Paula Arranz, Cristina Martínez Ostalé, Aintzane García-Bea, Inmaculada Gilaberte
Journal: Nutrients
Year: 2024

📄 Comparative inhibition by oral bilastine, parenteral dexchlorpheniramine, and a new bilastine parenteral (i.v. and i.m.) formulation of histamine-induced wheal and flare response: A randomised phase I trial

Authors: Coimbra, J., Puntes, M., Molina, P., Arranz, P., Sánchez, C.
Journal: European Journal of Pharmaceutical Sciences
Year: 2024

📄 Bioequivalence and Safety of Bilastine 20 mg Orodispersible Tablets and Conventional Tablets: A Randomized, Single-Dose, Two-Period Crossover Study in Healthy Volunteers Under Fasting Conditions

Authors: Román, M., Ochoa, D., Martin, S., Arranz, P., Sánchez, C.
Journal: Drugs in R and D
Year: 2024

📄 Disease Burden, Treatment Patterns, and Economic Impact of Rectovaginal Fistulas in Patients with Crohn’s Disease: Findings from a Retrospective, Observational, Longitudinal Study Based on US Claims Databases

Authors: Karki, C., Latremouille-Viau, D., Gilaberte, I., Romdhani, H., Lightner, A.L.
Journal: PharmacoEconomics
Year: 2023

📄 Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn’s Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial

Authors: Garcia-Olmo, D., Gilaberte, I., Binek, M., Spinelli, A., Panés, J.
Journal: Diseases of the Colon and Rectum
Year: 2022

Shadi Hamoud | Medicine and Dentistry | Best Researcher Award

Posted on 18/10/202418/10/2024 by Book of Award

Assist Prof Dr. Shadi Hamoud | Medicine and Dentistry | Best Researcher Award

Rambam Health Care Campus | Israel

Author Profile

Orcid

Early Academic Pursuits 🎓

Dr. Shadi Hamoud's academic journey began with the completion of his MD (cum laude) from the Faculty of Medicine at the Hebrew University, Jerusalem, in 1995. His commitment to medical excellence was evident from the beginning, as he specialized in Internal Medicine during his residency at Rambam Medical Center from 1996 to 2002. His passion for teaching also emerged early, as he served as a tutor and lecturer for medical students and advanced nursing courses at Rambam Health Care Campus.

Professional Endeavors 🏥

Dr. Hamoud has held several key roles throughout his career. Since 2010, he has been the Director of the Clinical Research Unit at the Internal Medicine E Department, Rambam Medical Center. He also serves as the Deputy Director of the same department. His expertise is sought by major pharmaceutical companies such as Bayer and Pfizer, where he has been a medical consultant since 2016 and 2017, respectively. Additionally, Dr. Hamoud plays a vital role on various medical committees, including the committee for blood product transfusions at Rambam and the specialty committee within the hospital.

Contributions and Research Focus 🔬

Dr. Hamoud's research interests are broad, focusing on critical issues in cardiovascular medicine, diabetes, and novel COVID-19 treatments. He has investigated lipoprotein oxidation and atherosclerosis, as well as the enzyme heparanase and its impact on kidney injuries, fatty liver disease, and other conditions. His involvement in international clinical trials and research on lipid-modifying drugs and new oral anticoagulants highlights his commitment to advancing medical science.

Accolades and Recognition 🏅

Dr. Hamoud has received numerous awards throughout his career, recognizing his dedication to both medicine and education. Between 2003 and 2016, he was named an Excellent Lecturer by the Internal Medicine E Department at Rambam Health Care Campus. In 2008, he was also honored with an Excellence in Medicine award, further cementing his reputation as a distinguished medical professional.

Impact and Influence 🌍

Dr. Hamoud’s influence extends beyond academia and clinical practice. He has been actively involved in public health education, delivering lectures at local schools in his hometown of Majd Al-Kurum. His role as an examiner in Israel’s internal medicine specialization exams underscores his commitment to shaping the next generation of medical professionals. He has also contributed to the medical field through his membership in professional societies, including the European Society of Hypertension and the Israeli Society of Hypertension.

Legacy and Future Contributions 🌱

Dr. Hamoud's work in medical research, clinical practice, and education has left a lasting impact on the healthcare field in Israel and beyond. His ongoing roles in clinical research, his contributions to new therapies for chronic diseases, and his mentorship of future doctors ensure that his influence will continue to grow. As a leader in both medicine and research, his legacy is one of commitment to improving health outcomes and advancing scientific knowledge for the benefit of future generations

Publications

📄"Gender-Specific Renoprotective Pathways in αMUPA Transgenic Mice Subjected to Acute Kidney Injury" 🐭
Authors: Heba Abd Alkhaleq, Shadi Hamoud, Israel Hacker, Tony Karram, Ahmad Fokra, Aviva Kabala, Zaid Abassi
Journal: International Journal of Molecular Sciences
Year: 2024

📄"Effects of Angiotensin 1-7 and Mas Receptor Agonist on Renal System in a Rat Model of Heart Failure" 🐀
Authors: Ravit Cohen-Segev, Omri Nativ, Safa Kinaneh, Doron Aronson, Aviva Kabala, Shadi Hamoud, Tony Karram, Zaid Abassi
Journal: International Journal of Molecular Sciences
Year: 2023

📄"Heparanase Inhibition Prevents Liver Steatosis in E₀ Mice" 🧬
Authors: Safa Kinaneh, Walaa Hijaze, Lana Mansour-Wattad, Rawan Hammoud, Hisam Zaidani, Aviva Kabala, Shadi Hamoud
Journal: Journal of Clinical Medicine
Year: 2022

Ylenia Della Rocca | Medicine and Dentistry | Best Researcher Award

Posted on 20/09/202420/09/2024 by Book of Award

Dr. Ylenia Della Rocca | Medicine and Dentistry | Best Researcher Award

University of Chieti | Italy

Author Profile

Scopus

Orcid

🌱 Early Academic Pursuits

Dr. Ylenia Della Rocca’s academic journey began with exceptional achievements in biotechnology. In 2018, she earned her degree in Biotechnology with a perfect score of 110/110 cum laude from the University of L'Aquila. Her thesis, centered on "Hairy Cell Leukemia," set the stage for her future in oncohematological genetics. She continued to excel with a Master’s degree in Medical Biotechnology, again graduating with academic praise. Her research on the HLA-G 3' UTR region in kidney transplantation at the National Research Center solidified her expertise in medical biotechnology.

🏥 Professional Endeavors

Currently, Dr. Della Rocca serves as a Researcher Technologist and Subject Expert in Histology and Embryology at the University of Chieti. Her impressive academic trajectory culminated in a Ph.D. in "Innovative Technologies in Clinical Medicine & Dentistry" in 2024. As part of her doctoral research, she developed a new iPS cell line during her tenure at the University of Barcelona and Josep Carreras Leukaemia Research Institute. Beyond her role as a researcher, Dr. Della Rocca has been a prominent speaker at numerous international conferences, where her work has garnered significant recognition.

🔬 Contributions and Research Focus

Dr. Della Rocca’s research is at the forefront of biotechnology and regenerative medicine. Her completed and ongoing projects include the development of three-dimensional disease models, studies on tissue differentiation, and the establishment of new iPS cell lines. She has also been pivotal in creating innovative models for carcinogenesis research. Her current patent under review—"Pluripotent Stem Cells Induced by Autologous Gingival Stem Cells and Extracellular Vesicles: A Novel Approach for Cardiac Regeneration"—underscores her groundbreaking contributions to stem cell therapies and regenerative medicine.

🏆 Accolades and Recognition

Dr. Della Rocca’s research career has been marked by numerous accolades, including two prestigious awards for her scientific achievements. She has been a Guest Editor for special issues in renowned journals like the International Journal of Molecular Sciences and has served as a Review Editor for Frontiers in Genetics and Frontiers in Cell and Developmental Biology. Her citation index of 10 reflects the growing impact of her research in the scientific community.

🌍 Impact and Influence

Dr. Della Rocca’s work transcends academic research, as evidenced by her collaborations with top universities and research institutes worldwide, including the University of Barcelona, IRCCS Sicily, and the University of Montreal. She is an active member of the Italian Society of Anatomy and Histology and the Sigma Xi Scientific Research Honor Society. Dr. Della Rocca’s commitment to healthcare is further exemplified by her founding of Associazione Sorrisi in Ospedale (A.S.I.O.), a third-sector organization aimed at improving patient care in hospitals.

🔮 Legacy and Future Contributions

As a leader in the fields of stem cells, bioengineering, and regenerative medicine, Dr. Ylenia Della Rocca continues to push the boundaries of scientific knowledge. Her contributions to cell-free therapies and the development of three-dimensional models hold immense promise for future medical applications. With her ongoing work in stem cell regeneration and epigenetic research, Dr. Della Rocca is poised to shape the next frontier of clinical and research tools, leaving a lasting legacy in biotechnology.

Publications

📄 Autologous hGMSC-Derived iPS: A New Proposal for Tissue Regeneration
Authors: Ylenia Della Rocca, Francesca Diomede, Fanì Konstantinidou, Valentina Gatta, Liborio Stuppia, Umberto Benedetto, Marco Zimarino, Paola Lanuti, Oriana Trubiani, Jacopo Pizzicannella
Journal: International Journal of Molecular Sciences
Year: 2024

📄 Biological Effects of PMMA and Composite Resins on Human Gingival Fibroblasts: An In Vitro Comparative Study
Authors: Ylenia Della Rocca, Enrico Matteo Traini, Oriana Trubiani, Tonino Traini, Antonella Mazzone, Guya Diletta Marconi, Jacopo Pizzicannella, Francesca Diomede
Journal: International Journal of Molecular Sciences
Year: 2024

Maria Margariti | Medicine and Dentistry | Best Researcher Award

Posted on 20/09/202420/09/2024 by Book of Award

Assoc Prof Dr. Maria Margariti | Medicine and Dentistry | Best Researcher Award

1st Department of Psychiatry, Medical School, National and Kapodistrian University of Athens | Greece

Author Profile

Google Scholar

Early Academic Pursuits 🎓

Dr. Maria Margariti embarked on her academic journey at the National and Kapodistrian University of Athens, where she earned her Diploma in Medicine in 1989. Her dedication to psychiatry led her to complete a fellowship training program in community psychiatry in the UK in 1991-1992. By 1995, she had achieved her Psychiatric Specialty Licensure and continued her education with a Ph.D. in Psychiatric Education, which she completed in 2000. Her early academic foundation laid the groundwork for a successful career in psychiatry.

Professional Endeavors 🏥

Since 2002, Dr. Margariti has been an integral part of the National and Kapodistrian University of Athens, where she progressed from Lecturer to her current position as Associate Professor of Psychiatry. She has been pivotal in various leadership roles, including heading the psychiatric emergencies and outpatient clinic at Eginition Hospital. Additionally, she founded the Crisis Intervention and Management Unit for severe psychiatric disorders, showcasing her commitment to advancing psychiatric care.

Contributions and Research Focus 🔍

Dr. Margariti’s research primarily focuses on psychiatric education and the psychopathology of psychosis. Her extensive clinical observations led to the recognition of a complex emotional state called ‘Psychotic Arousal.’ This groundbreaking concept highlights an increased affective tone and symptoms of experiential alienation in acute psychosis. Her work has opened new avenues for understanding the neurobiology of emotions and consciousness in the context of psychiatric disorders.

Accolades and Recognition 🏆

Dr. Margariti’s contributions to the field have not gone unnoticed. She has published 45 journals and is cited 716 times, reflecting the impact of her research. She has been involved in developing clinical guidelines for treating schizophrenia and has served as an advisor in various professional psychiatric organizations. Her leadership roles and innovative research have solidified her reputation in the psychiatric community.

Impact and Influence 🌍

Through her educational initiatives, Dr. Margariti has shaped the training of numerous medical students and trainee psychiatrists. Her involvement in postgraduate courses and mentorship has significantly influenced the next generation of psychiatric professionals in Greece. By addressing critical aspects of psychiatric education and psychopathology, her work continues to resonate within the medical community.

Legacy and Future Contributions 🔮

Dr. Margariti’s pioneering research on ‘Psychotic Arousal’ is poised to leave a lasting legacy in psychiatric literature. As she continues to explore the complexities of acute psychosis, her findings may lead to enhanced diagnostic and therapeutic approaches in psychiatry. With her ongoing commitment to research and education, she is well-positioned to make further significant contributions to the field.

Publications

📝 Psychotic Arousal and the Psychopathology of Acute Schizophrenia: An Exploratory Study of the Experiential Emotional State in Acute Psychosis
Authors: MM Margariti, II Vlachos, D Mpourazana, P Aristotelidis, M Selakovic, ...
Journal: Journal of Clinical Medicine
Year: 2024

📝 Frequent visitors in a university psychiatric emergency department in Greece
Authors: I Vlachos, P Chondraki, P Magioglou, E Lempesi, D Bourazana, ...
Journal: European Psychiatry
Year: 2022

📝 The concept of psychotic arousal and its relevance to abnormal subjective experiences in schizophrenia. A hypothesis for the formation of primary delusions
Authors: MM Margariti, II Vlachos
Journal: Medical Hypotheses
Year: 2022

📝Psychiatric specialty training in Greece: Comparative analysis of educational programs (2000 vs 2014)
Authors: M Margariti, C Papageorgiou
Journal: Psychiatrike= Psychiatriki
Year: 2017

Dong Hyun Kim | Medicine and Dentistry | Young Scientist Award

Posted on 18/09/202418/09/2024 by Book of Award

Dr. Dong Hyun Kim | Medicine and Dentistry | Young Scientist Award

Seoul National University College of Medicine | South Korea

Author Profile

Scopus

Orcid

Early Academic Pursuits 🎓

Dr. Dong Hyun Kim embarked on his medical journey at the prestigious Seoul National University College of Medicine, earning his Bachelor of Medicine in 2019. His academic rigor continued with a Master's degree in Medical Science, specializing in Translational Medicine, which he completed in 2024. His academic training laid the foundation for his future endeavors in clinical oncology and hematologic malignancies, blending medicine with cutting-edge research.

Professional Endeavors 🏥

Dr. Kim's professional career began at Seoul National University Hospital, where he completed his internship and then advanced to a Resident Doctor position in the Department of Internal Medicine. His expertise expanded into the field of Hemato-Oncology, where he currently serves as an External Clinical Researcher. His clinical work, especially in the realm of cancer treatment and translational medicine, has contributed significantly to patient care and scientific discovery.

Contributions and Research Focus 🔬

Dr. Kim’s research has made a considerable impact on hematologic malignancies and the use of artificial intelligence in oncology. His work spans various domains, including allogeneic stem cell transplantation, tumor-infiltrating lymphocytes as biomarkers, and predictive modeling in cancer treatment. Through his numerous publications, he has explored innovative treatments and personalized medicine, particularly focusing on improving patient outcomes in myelofibrosis, thymic epithelial neoplasms, and head and neck squamous cell carcinoma.

Accolades and Recognition 🏅

Dr. Kim has received numerous awards that underscore his contributions to the field. He earned the Best Oral Presentation Award at ICBMT 2022, a Presidential Oral Presentation at JSMO 2024, and another Best Oral Presentation Award at ICKSH 2024. These recognitions reflect his leadership in oncology research and his ability to present complex ideas with clarity and authority.

Impact and Influence 🌍

Through his published works, Dr. Kim has influenced the global oncology community. His research on artificial intelligence in oncology, predictive biomarkers, and innovative therapeutic approaches has opened new pathways in cancer treatment. His contributions, especially in improving treatment strategies for hematologic malignancies and solid tumors, are helping shape the future of personalized medicine.

Legacy and Future Contributions 🌟

Dr. Kim is poised to continue influencing the fields of clinical oncology and translational medicine. His dedication to research, combined with his clinical expertise, ensures that he will remain a key figure in advancing cancer treatment and improving patient outcomes. His future endeavors, backed by a solid academic and professional foundation, are expected to further elevate the standards of oncological care and research.

Publications

📄 Dual T-cell depletion with individually tailored anti-thymocyte globulin and attenuated dose of post-transplant cyclophosphamide in haploidentical peripheral stem cell transplantation
Author: Kim, D.H., Shin, D.-Y., Koh, Y., Byun, J.M., Hong, J.
Journal: Scientific Reports
Year: 2024

📄 Effects of tertiary palliative care on the pattern of end-of-life care in patients with hematologic malignancies in Korea
Author: Kim, D.H., Youk, J., Byun, J.M., Yoo, S.H., Shin, D.-Y.
Journal: European Journal of Haematology
Year: 2024

📄 Impact of PIK3CA and cell cycle pathway genetic alterations on durvalumab efficacy in patients with head and neck squamous cell carcinoma: Post hoc analysis of TRIUMPH study
Author: Kim, D.H., Lim, S.T., Kim, H.R., Shin, S.-H., Yun, H.J.
Journal: Oral Oncology
Year: 2024

📄 Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes as a predictive biomarker for axitinib in adenoid cystic carcinoma
Author: Kim, D.H., Lim, Y., Ock, C.-Y., Kim, S.-B., Keam, B.
Journal: Head and Neck
Year: 2023

Theodoros Grivas | Medicine and Dentistry | Lifetime Achievement Award

Posted on 28/08/202428/08/2024 by Book of Award

Dr. Theodoros Grivas | Medicine and Dentistry | Lifetime Achievement Award

Tzaneio General Hospital of Piraeus | Greece

Aurhor Profile

Scopus

Orcid

Google Scholar

🎓 Early Academic Pursuits

Dr. Theodoros B. Grivas began his illustrious journey in medicine by graduating from the Medical School at “Aristotle” University of Thessaloniki in 1978. His academic foundation was further solidified through comprehensive training in General Surgery, Paediatric and Adult Orthopaedics, and Traumatology in Greece. Driven by a passion for deepening his expertise, he pursued and earned a Ph.D. from the National and Kapodistrian University of Athens, establishing a robust foundation for his future contributions to orthopaedic and spinal surgery.

💼 Professional Endeavors

Throughout his career, Dr. Grivas worked at prestigious institutions, including the “University Hospital” at Queen’s Medical Centre in Nottingham, “Harlow Wood” Orthopaedic Hospital in Mansfield, UK, and prominent hospitals in Athens, Greece. Notably, he served as the Director of the Orthopaedics and Traumatology Department at “Thriasio” Hospital for five years and later at “Tzaneio” General Hospital of Piraeus for 12 years until his retirement in 2021. His leadership and expertise significantly impacted the field, where he played a pivotal role in advancing patient care and surgical practices.

🔬 Contributions and Research Focus

Dr. Grivas has an impressive record of scientific contributions, including over 645 scientific publications and presentations, with 136 indexed in Medline. His research spans various orthopaedic and spinal topics, with a particular focus on school screening programs and spinal deformities. As a principal investigator or collaborator, he was involved in 20 research projects, funded by national and European sources. Additionally, he established a National Training Center for school-screening examiners and was a key figure in implementing the School Screening program in Greece.

🏆 Accolades and Recognition

Dr. Grivas’s achievements have been recognized both nationally and internationally. He has served as a member and Traveling Fellow of renowned organizations like AAOS, AOA, and SRS. He held the presidency of the IRSSD, SOSORT (which he helped found), and the Hellenic Spine Society. His editorial contributions include serving as the Chief Editor of the BMC open access journal “Scoliosis and Spinal Deformities,” and as a member of the editorial board or a reviewer for several peer-reviewed journals. His department was also honored with the opportunity to provide the “Trialect platform” Fellowship in Orthopaedics and Traumatology.

🌍 Impact and Influence

Dr. Grivas’s influence extends beyond his immediate clinical work, impacting the broader medical community through his involvement in critical decision-making bodies. During 2019-2020, he served on the National Examination Committee for Orthopaedics and Traumatology and was a member of the Crisis and Selection Council of the Hellenic National Health System from 2020-2021, which is responsible for the appointment of Orthopaedic Surgeons in State Hospital Positions.

🚀 Legacy and Future Contributions

Even in retirement, Dr. Grivas continues to contribute to the field he has dedicated his life to. He is currently focused on establishing the Hellenic Scoliosis Foundation, aiming to further advance the understanding and treatment of scoliosis. His enduring legacy lies in his vast body of work, the numerous professionals he has mentored, and the patients whose lives he has improved through his expertise in orthopaedics and spinal surgery. His future contributions promise to leave a lasting impact on the field, continuing to inspire and guide the next generation of surgeons.

Publications

📄 Rib index is a strong surrogate of scoliometric reading in idiopathic scoliosis
Author(s): Grivas, T.B., Jevtic, N., Ljubojevic, D., Mamzari, A., Vasiliadis, E.
Journal: European Spine Journal
Year: 2024

📄 Cross-cultural adaptation, reliability and validity of the Greek version of the Spinal Appearance Questionnaire (SAQ) in patients with adolescent idiopathic scoliosis
Author(s): Oikonomaki, M., Kelalis, G., Skouras, A.Z., Georgoudis, G., Grivas, T.
Journal: Spine Deformity
Year: 2024

📄 A Questionnaire of Physiotherapeutic Specific Exercises of Scoliosis—QPSSE
Author(s): Grivas, T.B., Dadakaridou, D., Fokidi, S.A., Theodosopoulos, E., Griva, A.M.
Journal: Journal of Clinical Medicine
Year: 2024

📄 Menarche in Scoliotic and Non-Scoliotic Balkan Girls and the Relationship between Menarche and the Laterality of Scoliotic Curves
Author(s): Pjanic, S., Jevtic, N., Grivas, T.B.
Journal: Journal of Clinical Medicine
Year: 2024

📄 Segmental Rib Index and Spinal Deformity: Scoliogenic Implications
Author(s): Grivas, T.B., Jevtic, N., Ljubojevic, D., Golic, F., Vasiliadis, E.
Journal: Healthcare (Switzerland)
Year: 2023

Madawi Alotaibi | Medicine and Dentistry | Best Researcher Award

Posted on 08/08/202408/08/2024 by Book of Award

Assist Prof Dr. Madawi Alotaibi | Medicine and Dentistry | Best Researcher Award

Princess Noura bent Abdulrahman University | Saudi Arabia

Author Profile

Scopus

Orcid

🎓 Early Academic Pursuits

Dr. Madawi Alotaibi's academic journey is a testament to her dedication to the field of health and rehabilitation sciences. She earned her Bachelor of Science in Physical Therapy from King Saud University, Riyadh, in 2005, laying a strong foundation for her future endeavors. Continuing her academic pursuit, she completed a Master of Health Sciences in Pediatric Physical Therapy from the University of Indianapolis, USA, in 2011. Her passion for advancing in this domain led her to obtain a Doctor of Philosophy in Health and Rehabilitation Sciences with a minor in Health Policy and Management from Indiana University Purdue University, USA, in 2018. These academic achievements have equipped her with the knowledge and skills necessary to excel in her field.

🏥 Professional Endeavors

Dr. Alotaibi's professional career reflects a deep commitment to improving healthcare, particularly in the realm of physical therapy. She began her career at King Saud Medical City-Children Hospital as a Physical Therapist, where she served from August 2006 to December 2018. Her expertise and dedication led her to King Salman bin Abdulaziz Hospital, where she worked as a PT consultant from January 2019 to March 2020. Her leadership abilities were recognized, and she was appointed Deputy Director of Change Management at King Salman Hospital, a role she continues to hold. In this capacity, she has worked on numerous strategic projects at St. Francis and IU Health Hospitals, demonstrating her capability in both clinical and managerial aspects of healthcare.

🔬 Contributions and Research Focus

Dr. Alotaibi has made significant contributions to the field of rehabilitation, focusing on innovative solutions for individuals with physical disabilities. Her research interests are evident in her scholarly activities, which include publications on cerebral palsy, musculoskeletal pain, and the physiological responses of athletes with disabilities. Notably, she has developed various rehabilitation devices, including those for people with prosthetic limbs and sensory innovations, showcasing her commitment to improving the quality of life for patients through technology.

🏆 Accolades and Recognition

Dr. Alotaibi's work has been widely recognized both nationally and internationally. She has received numerous awards, including the prestigious Inventor Award at the Technology, Innovation, Pioneers Summit in Abu Dhabi in 2020, and the Saudi Female Inventor Award at Expo 2020 Dubai. Her inventions have garnered multiple medals at international exhibitions, including gold at the European Exhibition of Creativity and Innovation and the World Invention Creativity Olympic. These accolades highlight her innovative spirit and significant contributions to healthcare technology.

🌍 Impact and Influence

Dr. Alotaibi's impact extends beyond her clinical and research contributions. She has played a crucial role in shaping the future of healthcare education and innovation at Princess Nourah University, where she coordinates several committees and directs the Innovation Unit in the College of Health & Rehabilitation Sciences. Her work in these roles demonstrates her commitment to fostering a new generation of healthcare professionals who are equipped to meet the challenges of the future.

🔮 Legacy and Future Contributions

Dr. Madawi Alotaibi's legacy is one of innovation, dedication, and excellence in the field of health and rehabilitation sciences. Her pioneering work in developing rehabilitation devices and her influence in healthcare management have set a high standard for future professionals in the field. As she continues to innovate and lead, her contributions are sure to have a lasting impact on both the academic and healthcare communities, inspiring others to follow in her footsteps. Her future endeavors will undoubtedly continue to push the boundaries of healthcare, making significant strides in improving patient outcomes and advancing medical technology.

Publications 📚

📝 Neglect of Psychological Care for Children with Cerebral Palsy and Their Families and Its Impact on Their Occupational Engagement in Saudi Arabia
- Authors: Safaa M. Elkholi, Salwa S. Awad, Madawi H. Alotaibi
- Journal: Medicina
- Year: 2024

📝 The Pilot Study of the Effect of Six-Week Robot-Assisted Ankle Training on Mobility and Strength of Lower Extremity and Life Habits for Children with Cerebral Palsy
- Authors: Madawi H. Alotaibi, B.L. Arnold, N. Munk, S. Alqabbani, A. Almuwais
- Journal: Heliyon
- Year: 2024

📝 Relationship of Anthropometrics and Blood Pressure to Identify People at Risk of Hypertension and Obesity-Related Conditions in Nigerian Rural Areas
- Authors: Sunday O.G., S.-L. Okorie, E.A. Ogugua, Madawi H. Alotaibi, Safaa M. Elkholi
- Journal: Medicine (United States)
- Year: 2024

📝 Does the Effect of Mental Fatigue Created by Motor Imagery on Upper Extremity Functions Change with Diaphragmatic Breathing Exercises? A Randomized, Controlled, Single-Blinded Trial
- Authors: O.B. Türkmen, B. Akçay, C. Demir, Madawi H. Alotaibi, Safaa M. Elkholi
- Journal: Medicina (Lithuania)
- Year: 2024

📝 Pes Planus Level Affects Counter Movement Jump Performance: A Study on Amateur Male and Female Volleyball Players
- Authors: A. Kurtoğlu, B. Çar, Ö. Eken, Madawi H. Alotaibi, Safaa M. Elkholi
- Journal: Medicine (United States)
- Year: 2024

Livia Augustin | Medicine and Dentistry | Best Researcher Award

Posted on 05/08/202405/08/2024 by Book of Award

Dr. Livia Augustin | Medicine and Dentistry | Best Researcher Award

National Cancer Institute Pascale Napoli | Italy

Author Profile

Scopus

Early Academic Pursuits 🎓

Dr. Livia Augustin embarked on her academic journey with a Bachelor of Science in Nutritional Sciences and Human Biology from the University of Toronto in 1995, complemented by a minor in Psychology. Her passion for understanding the interplay between diet and health led her to pursue a Master of Science in Nutritional Sciences at the same institution, where she investigated the effects of wheat bran on serum lipids and colonic health. Dr. Augustin's quest for deeper knowledge culminated in a Doctor of Philosophy in Human Health and Nutritional Sciences from the University of Guelph in 2010. Her thesis explored the dietary glycemic index's implications on cancer risk, growth factors, and oxidative stress, marking a significant contribution to nutritional science.

Professional Endeavors 🌟

Dr. Augustin's professional career has been distinguished by her roles as a Nutrition Researcher and Study Coordinator at the National Cancer Institute Fondazione G. Pascale in Naples, Italy, since 2015. Her work has spanned across various esteemed institutions, including the Centro Riferimento Oncologico, Clinical Nutrition and Risk Factor Modification Centre at St. Michael’s Hospital, and the University of Milan. Her international collaborations extend to King's College London, Brighton University, and the Hellenic Health Foundation. Previously, she has worked at Unilever R&D, the Clinical Nutrition and Risk Factor Modification Centre, and as a Research Assistant at the Department of Epidemiology and the University of Toronto.

Contributions and Research Focus 🔬

Dr. Augustin's research has significantly advanced the understanding of lifestyle factors and their impact on cancer. Her notable studies include evaluating the long-term effects of integrated lifestyle treatments on breast cancer survivors and examining the influence of diet, exercise, and vitamin D supplementation on breast cancer recurrence. Her research has explored dietary habits, physical activity, and psychological states in breast cancer survivors, contributing valuable insights into improving quality of life and health outcomes in this population.

Accolades and Recognition 🏆

Dr. Augustin's contributions to nutritional science and cancer research have been recognized through several substantial grants. She has led projects funded by the Italian Ministry of Health and various Italian cancer research organizations, including LILT and the Lega Italiana per la Lotta contro i Tumori. Her grants support significant research into dietary interventions, cancer prevention, and quality of life improvements for cancer patients.

Impact and Influence 🌍

Dr. Augustin's work has had a profound impact on the field of nutrition and cancer research, influencing dietary recommendations and lifestyle interventions aimed at reducing cancer risk and improving patient outcomes. Her leadership in organizing scientific events and her role as a university speaker have further cemented her position as a leading figure in her field.

Legacy and Future Contributions 🌱

Looking ahead, Dr. Augustin continues to shape the future of nutritional science through her innovative research and commitment to improving cancer care. Her ongoing projects and collaborations promise to further advance our understanding of diet and lifestyle's role in health and disease. Her dedication to research supervision and student training also ensures that the next generation of scientists will benefit from her expertise and passion.

Publications 📘

📄Baseline Association between Healthy Eating Index-2015 and Health-Related Quality of Life in Breast Cancer Patients Enrolled in a Randomized Trial
Authors: Porciello, G., Coluccia, S., Vitale, S., Celentano, E., Augustin, L.S.A.
Journal: Cancers
Year: 2024

📄Diabetes Risk Reduction Diet and Colorectal Cancer Risk
Authors: Natale, A., Turati, F., Taborelli, M., Rossi, M., Vecchia, C.L.
Journal: Cancer Epidemiology Biomarkers and Prevention
Year: 2024

📄Central Obesity, Body Mass Index, Metabolic Syndrome and Mortality in Mediterranean Breast Cancer Patients
Authors: Crispo, A., Augustin, L.S.A., Luongo, A., La Vecchia, C., Arpino, G.
Journal: Scientific Reports
Year: 2023

📄Diabetes Risk Reduction Diet and Ovarian Cancer Risk: An Italian Case-Control Study
Authors: Esposito, G., Turati, F., Parazzini, F., Negri, E., La Vecchia, C.
Journal: Cancer Causes and Control
Year: 2023

📄One-Year Nutrition Counselling in the Context of a Mediterranean Diet Reduced the Dietary Inflammatory Index in Women with Breast Cancer: A Role for the Dietary Glycemic Index
Authors: Vitale, S., Palumbo, E., Polesel, J., Jenkins, D.J.A., Augustin, L.S.A.
Journal: Food and Function
Year: 2023